Efficacy of stereotactic radiosurgery for radiation-induced meningiomas.


Journal

Journal of neuro-oncology
ISSN: 1573-7373
Titre abrégé: J Neurooncol
Pays: United States
ID NLM: 8309335

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 27 02 2020
accepted: 22 04 2020
pubmed: 29 4 2020
medline: 17 4 2021
entrez: 29 4 2020
Statut: ppublish

Résumé

Stereotactic radiosurgery is an established treatment option for sporadic meningiomas, though limited data exists for radiation-induced lesions. Patients treated with cobalt-60 radiosurgery between October 2005 and December 2018 in an institutional registry were reviewed. Single fraction treatments were prescribed to the 50% isodose line. Lesions were deemed to be radiation-induced according to standard criteria previously established by Cahan et al. RESULTS: A total of 37 patients with 72 lesions were analysed. Median follow up per patient was 44 months (range, 1.4-150.7 months). Median age at initial radiotherapy was 5 years (4 months-48 years), and at radiosurgery was 38 years. Of the 72 lesions, 62 were grade 1 (n = 4) or radiologically-diagnosed (n = 58), six were grade 2 and four were grade 3. Median lesion volume was 2.13 cc (0.04-13.8 cc), while the median radiosurgery margin dose was 13 Gy. Local control, on a per lesion basis, was 88.6% at 5 years (95% confidence interval [CI] 72.3-95.6). For grade 1 or radiologically-diagnosed lesions, local control was 96.6% at 5 years (95% CI 77.9-99.5), whereas those with grade 2 or higher lesions had a local control of 40% at 5 years (95% CI 5.2-75.3, p = 0.005). Radiologic oedema developed in 17 lesions (23.6%) and was symptomatic in 12 patients (16.7%). Doses above 12 Gy were not associated with local control probability (p = 0.292). Radiosurgery is an effective treatment option for grade 1 or radiologically-diagnosed radiation-induced meningiomas, with 12 Gy appearing to be a sufficient dose.

Identifiants

pubmed: 32342330
doi: 10.1007/s11060-020-03515-7
pii: 10.1007/s11060-020-03515-7
doi:

Substances chimiques

Cobalt 3G0H8C9362

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

299-305

Auteurs

Michael Huo (M)

Princess Margaret Cancer Centre, Toronto, Canada. michael.huo@health.qld.gov.au.
The University of Toronto, Toronto, Canada. michael.huo@health.qld.gov.au.
The University of Queensland, Brisbane, Australia. michael.huo@health.qld.gov.au.

Normand Laperriere (N)

Princess Margaret Cancer Centre, Toronto, Canada.
The University of Toronto, Toronto, Canada.

Monique van Prooijen (M)

Princess Margaret Cancer Centre, Toronto, Canada.
The University of Toronto, Toronto, Canada.

David Shultz (D)

Princess Margaret Cancer Centre, Toronto, Canada.
The University of Toronto, Toronto, Canada.

Catherine Coolens (C)

Princess Margaret Cancer Centre, Toronto, Canada.
The University of Toronto, Toronto, Canada.

Mojgan Hodaie (M)

The University of Toronto, Toronto, Canada.
Toronto Western Hospital, Toronto, Canada.

Michael Cusimano (M)

The University of Toronto, Toronto, Canada.
St Michael's Hospital, Toronto, Canada.

Fred Gentili (F)

The University of Toronto, Toronto, Canada.
Toronto Western Hospital, Toronto, Canada.

Gelareh Zadeh (G)

The University of Toronto, Toronto, Canada.
Toronto Western Hospital, Toronto, Canada.

David Payne (D)

Princess Margaret Cancer Centre, Toronto, Canada.
The University of Toronto, Toronto, Canada.

Michael Schwartz (M)

The University of Toronto, Toronto, Canada.
Toronto Western Hospital, Toronto, Canada.

Derek S Tsang (DS)

Princess Margaret Cancer Centre, Toronto, Canada.
The University of Toronto, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH